Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab plus docetaxel for recurrent or metastatic head and neck cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Phase II Study of 250-mg ZD1839 Monotherapy in Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma [Phase 2]
A Phase II study evaluating 250-mg ZD1839 (gefitinib) as monotherapy in recurrent/metastatic head and neck squamous cell carcinoma has been …
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients [Phase 2]
Phase II trial of pemetrexed-based induction chemotherapy followed by chemoradiotherapy in previously irradiated head and neck cancer patien…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Safety and Superiority of Penicillamine in Radiosensitization of Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial update investigating safety and potential superiority of penicillamine as a radiosensitizer for recurrent head and neck cancer…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant immunotherapy with ipilimumab and nivolumab prior to surgery in advanced or recurrent head and neck c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-02Clinical Trial Update: Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma [NA]
A completed clinical trial evaluating the pharmacodynamic effects of ribavirin in patients with tonsil and/or base of tongue squamous cell c…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds [Phase 2]
Phase 2 clinical trial update assessing the benefits of morphine gel in reducing pain for cancer-related wounds.
-
FDA approval · 2023-09-15FDA Approved: DOCETAXEL — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for docetaxel from Gland Pharma Limited under an ANDA for the generic product.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Study of KeraStat Cream for Radiation Dermatitis During Head and Neck Radiotherapy [NA]
A clinical trial evaluating KeraStat Cream for radiation dermatitis during head and neck radiotherapy has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Multimodal Pain Study in Free Flap Patients [Phase 4]
Phase 4 clinical trial update on multimodal pain management in free flap patients for head and neck cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) 2.0 [NA]
A completed clinical trial (BRIGHT 2.0) investigating renewal strategies after head and neck cancer treatment; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor [Phase 2]
Phase 2 trial assessing cisplatin or carboplatin with gemcitabine for locally advanced, recurrent, or metastatic malignant salivary gland tu…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy [Phase 3]
Phase 3 trial update evaluating a bandage skin hydrogel to alleviate pain in head and neck cancer patients treated with radiotherapy.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 clinical trial updating induction chemotherapy followed by surgery for locally advanced head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer [Phase 3]
Phase 3 trial comparing methotrexate to paclitaxel in advanced head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Paclitaxel in Treating Patients With Advanced Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel in patients with advanced head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer [Phase 2]
Phase 2 trial update evaluating irinotecan and docetaxel for metastatic or locally recurrent head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer [Phase 3]
A Phase III trial evaluated low-dose 13-cisretinoic acid for prevention of second primaries in patients with Stage I–II head and neck cancer…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 3]
Phase 3 trial investigating isotretinoin, interferon alfa, and vitamin E for stage III/IV head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer [Phase 2]
Phase 2 clinical trial evaluating paclitaxel in patients with metastatic or recurrent salivary gland cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer [Phase 2]
Phase 2 clinical trial updating the use of chemotherapy and radiation therapy for stage III/IV larynx or oropharynx cancer in head and neck …
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy [Phase 4]
Phase 4 clinical trial evaluating pharmacokinetics and pharmacogenetics-based adaptive dosing of 5-fluorouracil during TPF therapy in head a…